Drug resistance

WHO Global Strategy Recommendations

Fundamental priority recommendations are underlined and highlighted in bold
Other first priority recommendations are highlighted in bold.

Pharmaceutical Promotion

7.1 Introduce requirements for pharmaceutical companies to comply with national or international codes of practice on promotional activities.

7.2 Ensure that national or internationally codes of practice cover direct-to-consumer advertising, including advertising the Internet.

7.3 Institute systems for monitoring compliance with legislation on promotional activities.

7.4 Identify and eliminate economic incentives that encourage inappropriate antimicrobial use.

7.5 Make prescribers aware that promotion in accordance with the datasheet may not necessarily constitute appropriate antimicrobial use.